Restricted IgG1 subclass of anti-Yo antibodies in paraneoplastic cerebellar degeneration

Journal of Neuroimmunology

Volumn 114, Issue 1-2, 2001, Pages 259-264

  Amyes, Elisabeth ^a   Curnow, John ^a   Stark, Zornitza ^a   Corlett, Louise ^a   Sutton, Ian ^a   Vincent, Angela ^a,b  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

Anti Yo antibody; Cerebellar; IgG subclass; Paraneoplastic

Indexed keywords

IMMUNOGLOBULIN G1; INTERLEUKIN 4;

ANIMAL CELL; ARTICLE; CELL LOSS; CELL PROLIFERATION; CEREBELLUM DEGENERATION; COMPLEMENT ACTIVATION; HELPER CELL; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; NONHUMAN; PARANEOPLASTIC NEUROPATHY; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PURKINJE CELL; RAT; T LYMPHOCYTE ACTIVATION;

ANIMALS; AUTOANTIBODIES; AUTOANTIGENS; CELL DIVISION; DNA-BINDING PROTEINS; HU PARANEOPLASTIC ENCEPHALOMYELITIS ANTIGENS; HUMANS; IMMUNOGLOBULIN G; INTERFERON TYPE II; INTERLEUKIN-4; NEOPLASM PROTEINS; NERVE TISSUE PROTEINS; PARANEOPLASTIC CEREBELLAR DEGENERATION; RATS; RATS, INBRED LEW; RNA-BINDING PROTEINS; TH1 CELLS; TH2 CELLS;

EID: 0035283426     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(00)00445-8     Document Type: Article

References (25)

1. Functional diversity of helper T lymphocytes
2. Inhibition of the growth of human melanoma metastases in nude mice by melanoma-specific murine monoclonal antibody
3. Detection and treatment of activated T cells in the cerebrospinal fluid of patients with paraneoplastic cerebellar degeneration
4. Tumor-specific killer cells in paraneoplastic cerebellar degeneration
5. Autoantibodies in paraneoplastic syndromes associated with small-cell lung cancer
6. Cell-mediated autoimmunity in paraneoplastic neurological syndromes with anti-Hu antibodies
7. IgG subclass antibodies to glutamic acid decarboxylase and risk for progression to clinical insulin-dependent diabetes
8. Partial characterization of the Purkinje cells antigens in paraneoplastic cerebellar degeneration
9. Anti-Hu associated paraneoplastic encephalomyelitis/sensory neuropathy
10. Heterogeneous IgG subclass distribution of islet cell antibodies
11. Comparison of IgG subclass autoantibodies in patients with systemic lupus erythematosus and subacute cutaneous lupus erythematosus
12. Autoimmunity in paraneoplastic neurological syndromes
13. Analysis of the IgG subclass distribution and inflammatory infiltrates in patients with anti-Hu-associated paraneoplastic encephalomyelitis
14. Shift in the IgG subclass distribution in patients with lung cancer
15. Mouse monoclonal antibodies for experimental immunotherapy promotes killing of tumour cells
16. Immunoglobulins class and IgG subclass distribution of anticardiolipin antibodies in patients with systemic lupus erythematosus and associated disorders
17. Favourable prognosis in Lambert-Eaton myasthenic syndrome and small-cell lung cancer
18. Paraneoplastic cerebellar degeneration I. A clinical analysis of 55 anti-Yo antibody-positive patients
19. Autoimmune paraneoplastic cerebellar degeneration: Ultra structual localization of antibody-binding sites in Purkinje cells
20. Long-term clinical outcome of paraneoplastic cerebellar degeneration and anti-Yo antibodies
21. Lymphokine production by human T cells in disease states
22. Anti-Yo antibodies and cerebellar degeneration in a man with adrenocarcinoma of the oesophagus
23. Cytotoxic T cells against a peptide of Yo protein in patients with paraneoplastic cerebellar degeneration and anti-Yo antibody
24. Distribution of IgG subclasses among human autoantibodies to Sm, RNP, dsDNA, SS-B and IgG rheumatoid factor